Skip to main content
. 2018 Jan 25;13(1):e0190878. doi: 10.1371/journal.pone.0190878

Table 2. Correlation between the total number of cerebral microbleeds and demographics, drugs, clinical and other neuroimaging features in 125 CADASIL patients.

Number of CMB
mean (SD)
p* p**
Male gender (yes vs no) 3.8 (9.9) vs 3.8 (10.9) 0.981 0.676
Ischemic stroke (yes vs no) 5.5 (11.3) vs 2.7 (9.7) 0.144 0.980
TIA (yes vs no) 7.8 (17.1) vs 3.0 (8.6) 0.065 0.662
Recurrent ischemic events (yes vs no) 5.6 (9.8) vs 3.2 (10.6) 0.286 0.501
Hemorrhagic stroke (yes vs no) 25.3 (21.8) vs 3.3 (9.5) <0.001 0.001
Cognitive impairment (yes vs no) 8.8 (15.3) vs 0.8 (3.6) <0.001 0.140
Dementia (yes vs no) 22.4 (24.2) vs 2.4 (6.9) <0.001 <0.001
Psychiatric disturbances (yes vs no) 4.0 (8.9) vs 3.6 (11.5) 0.833 0.575
Migraine (yes vs no) 1.3 (4.4) vs 8.8 (16.0) <0.001 <0.001
Migraine with aura (yes vs no) 1.1 (4.7) vs 6.3 (13.3) 0.005 0.004
Prolonged aura (yes vs no) 0.4 (1.0) vs 4.1 (10.9) 0.169 0.141
Seizures (yes vs no) 9.6 (15.0) vs 3.2 (9.7) 0.051 0.265
Acute reversible encephalopathy (yes vs no) 1.2 (2.8) vs 4.1 (11.0) 0.306 0.246
Urge incontinence (yes vs no) 12.0 (17.8) vs 1.4 (5.2) <0.001 0.008
Hypertension (yes vs no) 8.0 (15.7) vs 2.0 (6.4) 0.003 0.650
Diabetes (yes vs no) 7.3 (15.8) vs 3.6 (10.0) 0.363 0.870
Hypercholesterolemia (yes vs no) 5.0 (10.0) vs 2.5 (11.2) 0.199 0.721
History of smoking (yes vs no) 3.4 (9.1) vs 4.2 (11.6) 0.680 0.821
Hyperhomocysteinemia (yes vs no) 6.4 (15.8) vs 3.4 (8.9) 0.236 0.386
Antithrombotic treatment (yes vs no) 5.0 (12.0) vs 1.6 (6.1) 0.111 0.450
Statins use (yes vs no) 3.8 (7.5) vs 3.9 (12.2) 0.967 0.009
Fazekas grade 1 (yes vs no) 0.0 (0.0) vs 4.6 (11.3) 0.036 0.429
Fazekas grade 2 (yes vs no) 0.2 (0.5) vs 4.4 (11.3)
Fazekas grade 3 (yes vs no) 5.7 (12.4) vs 0.1 (0.3)
Pontine leukoaraiosis (yes vs no) 5.9 (13.0) vs 0.9 (3.9) 0.007 0.918
Temporal pole involvement (yes vs no) 4.0 (10.7) vs 2.5 (8.2) 0.619 0.968
External capsule involvement (yes vs no) 4.9 (11.6) vs 0.0 (0.2) 0.026 0.106
Lacunar infarcts (yes vs no) 5.8 (12.5) vs 0.2 (1.2) 0.003 0.916

CADASIL: Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy; CMB: cerebral microbleeds; SD: standard deviations; TIA: transient ischemic attack

* ANOVA

** ANOVA adjusted for age

p values reported in bold are statistically significant